News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Instituto Mexicano del Seguro Social (IMSS) Chooses Stanbio Laboratory Hemoglobin Testing System


12/14/2011 10:08:32 AM

BOERNE, TX, December 14, 2011 – The Instituto Mexicano del Seguro Social (IMSS) has chosen Stanbio Laboratory to supply more than 3,500 of its point-of-care HemoPoint® H2 meters and related cuvette supplies for its IMSS OPORTUNIDADES program. The IMSS OPORTUNIDADES initiative is a government health program focused on underserved populations throughout Mexico’s 31 states. IMSS is the largest social security institution in Latin America.

The goal of the IMSS OPORTUNIDADES program is to improve quality of life through preventive diagnostics by identifying conditions such as diabetes, malnutrition, high blood pressure, high cholesterol, anemia, and other epidemiological diseases. The program will care for a broad range of Mexico’s 10.4 million IMSS program members, including the unemployed, farmers, single mothers, and the population’s lowest income people.

“It is an honor and a privilege to be selected by Mexico’s IMSS department to provide our HemoPoint® H2 point-of-care system for their IMSS OPORTUNIDADES program,” said Stanbio Laboratory President, William R. Pippin. “Our instruments and cuvettes are regarded as the premium choice for near-patient hemoglobin testing in U.S. public health clinics, physician offices and hospitals because of their ease-of-use, accuracy and reliability. We are extremely proud to be partnering with the IMSS and government of Mexico to help provide this much needed healthcare product and service to its most deserving people,” Pippin added.

The IMSS OPORTUNIDADES program assists in providing care in 3,595 clinics, 270 urban attention centers, 225 itinerant units, and 79 hospitals across the Mexican territory. Testing for anemia with the HemoPoint® H2 meter is expected to grow at a rate of 15 – 20% per year throughout Mexico during a five year period.

Founded in 1960 and headquartered in Boerne, Texas, Stanbio Laboratory manufactures and markets medical testing and diagnostic devices including clinical chemistry, pregnancy, strep A, serology, urinalysis, and point-of-care hemoglobin tests. Stanbio Laboratory’s Quality System is ISO 13485 registered and its facility operates under USFDA current GMP requirements. Stanbio also offers OEM and private labeling capabilities and distributes products in over 125 countries worldwide. This year the company celebrates its 51st year in business. To find out more about Stanbio, review its news, or learn more about its products, visit www.stanbio.com.

EKF Diagnostics Holdings plc is a worldwide manufacturer of near-patient care equipment for the measurement of glucose, lactate, hemoglobin, hematocrit and glycated hemoglobin (HbA1c). It offers its products to the professional clinical and research laboratories, doctors’ offices, sports clinics, and athletic testing sites. The company is headquartered in London, the United Kingdom.

IMSS is the largest social security institution in Latin America and a fundamental pillar for individual and collective well-being and critical for the redistribution of the nation’s wealth. As a service provider, the institution promotes the health of the nation’s insured working population, workers’ families, pensioners and students through a comprehensive system of services that includes preventive and curative medical services.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES